Should I buy Nufarm stock in 2025?

Why trust HelloSafe ?

At HelloSafe, our expert has been tracking Nufarm's performance for over three years. Every month, hundreds of thousands of users in Australia trust us to analyse market trends and identify the best investment opportunities. Our analyses are provided for informational purposes and do not constitute investment advice. In accordance with our ethical charter, we have never been, and will never be, paid by Nufarm.

What is Nufarm?

The price of Nufarm stock

The price of Nufarm stock is rising this week. Shares are currently priced at AU$2.45, with a 24-hour gain of 0.41% and a weekly loss of 2.08%. Nufarm holds a market capitalization of AU$938.31 million, and its average 3-month trading volume is 2.54 million shares. The stock does not have a positive P/E ratio due to negative results, offers a dividend yield of 3.80%, and has a low beta of 0.38. While recent volatility has been noticeable, the company’s strategic initiatives may support future recovery.

Our full analysis of the Nufarm stock

We have analysed Nufarm’s most recent financial results alongside the stock’s trajectory over the past three years, employing a multidimensional approach powered by proprietary algorithms. Drawing on financial indicators, up-to-date technical signals, sector comparisons, and relative value screens, our assessment is designed to offer readers an informed perspective. So, why might Nufarm stock once again become a strategic entry point into the agricultural technology sector in 2025?

Recent performance and market context

Nufarm has experienced a challenging year, with its share price falling by over 46% year-on-year to AU$2.45 as of July 2025. However, the last quarter brought encouraging signs: management’s strategic initiatives and continued revenue growth have started to attract market attention. Notably, the company reported a resilient revenue increase of 3% in the first half of 2025, even as conditions remained tight globally for crop protection and inputs. Management’s recent share purchases further underscore growing internal confidence. This is all set against a context where the global need for sustainable agricultural solutions is at an all-time high, creating renewed interest in key sector players with innovative capabilities.

Technical analysis

Technical momentum for Nufarm is quietly building, with several indicators suggesting a potential short- to medium-term inflection point. The stock now trades above its 20-, 50-, 100- and 200-day moving averages, a classic bullish alignment often preceding rebounds in blue-chip agri stocks. Nufarm’s Relative Strength Index (RSI) sits at a neutral 51.78, pointing to renewed technical flexibility after a period of oversold conditions. Meanwhile, the MACD signal has turned positive (+0.01), and nearest technical supports at AU$2.42 and AU$2.38 have held firm, suggesting downside risk is contained. Resistance zones at AU$2.49–2.56 are within striking distance if momentum accelerates. Combined with moderate volatility (beta of 0.38), these factors support a constructive technical setup.

Fundamental analysis

At the fundamental level, Nufarm’s story is defined by resilient top-line growth and a proactive strategic focus. First-half 2025 revenue rose to AU$1.81 billion, underscoring the company’s capacity to generate growth even in demanding conditions. While EBITDA declined 6% to AU$206 million—primarily due to pricing pressures in omega-3 and inventory write-downs—margin expansion should resume as bioproduct initiatives and new partnerships bear fruit. Nufarm’s historical and projected innovation pathways in seed technology, omega-3 crop applications, and biocarbon are catalysts for margin and market share improvement. A forward dividend yield of 3.80% provides tangible investor returns, and the company’s relative valuation (with a market cap below AU$1 billion) implies significant upside should normalization occur. Moreover, the group’s broad international reach, trusted brand, and investment in sustainable solutions set it apart structurally within the agri-tech space.

Volume and liquidity

Nufarm exhibits robust daily trading volumes averaging 2.54 million shares, evidence of sustained institutional and private investor interest even at current levels. With 304.42 million shares in the public float and 77% institutional ownership, Nufarm’s liquidity profile affords efficient entry and exit into positions. The dynamic between high liquidity and a manageable float creates a supportive atmosphere for price discovery and future valuation resets, particularly attractive to both retail and sophisticated investors seeking exposure to agricultural innovation.

Catalysts and positive outlook

• The company is poised to triple carinata plantation acreage in 2025, positioning itself as a major supplier of next-generation biofuel feedstocks.
• New agreements with blue-chip partners like BP and Unilever highlight the commercial potential of downstream bioproducts.
• Nufarm’s partnership with ChrysaLabs and commitment to measuring carbon innovation will enable it to capture ESG-focused capital inflows.
• Management’s actions to reduce inventory by 22 days on an annualised basis aims to improve working capital and provide additional operational flex.
• Continued strategic exploration of alternative capital structures for seed technologies could unlock previously untapped value streams.

These positive developments come at a time when macro policy initiatives are increasingly incentivising regenerative agriculture and low-carbon farming, offering supportive winds to sector leaders such as Nufarm.

Investment strategies

Nufarm now stands out as a strong candidate for accumulation both at present technical levels and in anticipation of further positive catalysts. For short-term investors, entry at technical supports (AU$2.42–2.38) presents a defined risk/reward scenario, especially if sector rotation brings renewed appetite for agri-tech. Medium-term strategists may appreciate the alignment of recent management purchases, technical upside, and the growing revenue contribution from new bioproduct agreements. Long-term investors can leverage the company’s dominant position in crop protection, the innovation pipeline, and expected margin recovery as sector headwinds abate. Those building core positions could see notable medium-term capital gains should consensus price targets (AU$3.60) be achieved—a substantial +47% upside from the current price.

Is it the right time to buy Nufarm?

Nufarm’s strengths—ongoing innovation, strategic global partnerships, rising demand for sustainable bio-based products, and a supportive liquidity profile—justify renewed optimism for the stock’s performance ahead. Trading near multi-year lows, with robust institutional backing and multiple company-driven and sector-driven growth levers, Nufarm seems to represent an excellent opportunity for investors seeking exposure to agricultural transformation. Though some challenges remain, the current valuation, technical configuration, and expanding product suite support the view that Nufarm may be entering a new bullish phase in 2025. For Australians looking to position themselves around the key food security and sustainability trends, Nufarm’s prospects for both absolute and relative outperformance appear compelling.

Nufarm offers a timely entry point into the fast-evolving agri-innovation landscape, and its combination of volatility and strategic momentum makes it a stock worth serious consideration as the next market cycle unfolds.

How to buy Nufarm stock in Australia

Buying Nufarm stock online is straightforward and secure for Australian investors using a regulated broker. You can choose between two main ways: spot buying, where you own the actual shares, or trading Contracts for Difference (CFDs) for leveraged exposure without owning the shares. Each method has its own advantages, depending on your investment approach and risk tolerance. For a detailed comparison of leading brokers, please refer to the broker comparison further down this page.

Spot buying

Spot (cash) buying means purchasing Nufarm shares directly and becoming a shareholder. You pay a fixed commission per trade, generally around AU$5–AU$10 with most well-known brokers.

Gain scenario

If the Nufarm share price is AU$2.45, you can buy around 408 shares with a AU$1,000 stake, including a brokerage fee of around AU$5.

If the share price rises by 10%, your shares are now worth AU$1,100.

Result: +AU$100 gross gain, i.e. +10% on your investment.

Trading via CFD

CFD trading enables you to speculate on Nufarm’s share price movements without actually owning the shares. Instead of a commission, you’ll generally pay the spread (difference between buy and sell price), plus overnight financing costs if you keep the position open after market hours.

Example of a Winning CFD Trade with Leverage

You open a CFD position on Nufarm shares, with 5x leverage. This gives you a market exposure of AU$5,000 with a AU$1,000 stake.

✔️ Gain scenario: If the stock rises by 8%, your position gains 8% × 5 = 40%.

Result: +AU$400 gain, on a bet of AU$1,000 (excluding fees).

Final advice

Always compare brokerage fees, available features, and investor protections before making any transaction—our broker comparison below will help you in your choice. Ultimately, which method you use should depend on your financial goals, appetite for risk, and investing experience.

Our 7 tips for buying Nufarm stock

The latest news about Nufarm

Technical indicators for Nufarm have turned positive, with all major moving averages now giving buy signals. Over the past week, the 20-, 50-, 100-, and 200-day moving averages have shifted to an upward bias, suggesting increasing market support for the stock despite previous volatility and underperformance. This is reinforced by a neutral RSI and a positive MACD, highlighting a potential trend reversal for Australian investors monitoring entry points.

Nufarm’s management has signalled strong confidence by conducting multiple insider share purchases in recent days. Recent filings report that several directors and executives have acquired Nufarm shares on the open market. This insider activity is interpreted as a positive signal regarding the company’s medium-term prospects and may help restore investor confidence after challenging months.

Nufarm has advanced its biofuels strategy by announcing expanded partnerships and new sustainability metrics initiatives. In the last week, Nufarm confirmed the deepening of its collaboration with ChrysaLabs to enhance carbon measurement in biofuel crops, as well as progress in work with BP and Unilever. These initiatives reinforce the company's commitment to innovation and sustainability while positioning it as a central player in Australia’s growing sustainable agriculture sector.

The company has set ambitious targets for reducing channel inventory levels by year-end, supporting operational efficiency. By successfully cutting average inventory days from 22 to an expected 25 by the close of the fiscal year, Nufarm is improving capital discipline and supply chain resilience. This initiative is expected to bolster financial flexibility and better position the company for market recovery.

Market sentiment for Nufarm has shifted to cautiously optimistic, backed by analyst forecasts and recent operational adjustments. While short-term challenges remain, the stock’s projected price target of $3.60 AUD (a 47% increase from current levels) and the strengthening of Nufarm’s leadership in the agricultural inputs sector are being recognized by local analysts as grounds for a constructive medium- to long-term outlook.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.